Temsirolimus safety evaluation: real-world adverse event analysis from the FDA adverse event reporting system database

Naunyn-Schmiedeberg s Archives of Pharmacology 2026

View at publisher

Authors: Lifeng Dan, Zhenyu Liu, Zecang Zhao, Yueli Ran, Jiangtao Zhou, Dongyang Li, Renjie Zhou, Shuai Su, Zhikang Yin

DOI: 10.1007/s00210-026-05233-9

Cited by: 1

References: 92

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions PI3K/AKT/mTOR signaling in cancer Renal cell carcinoma treatment

References 92